- Email: [email protected]
Millipore and HyClone form bioprocessing alliance
ISSN 0958-2118 March 2004 www.filtsep.com
Polypore agrees to be acquired by Warburg Pincus EC approves GE Polypore develops, manufactures and markets takeover of Amersham Polypore Inc, a US-based supplier of membranes and filtration products, has entered into a definitive agreement under which it will be acquired by affiliates of Warburg Pincus LLC from shareholders led by The InterTech Group Inc and GTCR Golder Rauner LLC. The agreement is subject to customary closing conditions, including regulatory approval, and the transaction is expected to be completed during the second quarter of 2004. The terms of the sale were not disclosed. ‘Warburg Pincus’ global franchise and domain expertise in the industrial, technology and healthcare sectors were instrumental in our ability to execute this investment and understand the potential of Polypore,’ says Kewsong Lee, a Warburg Pincus managing director. David Donnini, senior principal at GTCR, comments: ‘Over the course of our ten-year investment, Polypore has grown from a niche manufacturer of membranes into a leading global company serving multiple high-growth markets.’
specialized microporous filtration products used in the power, storage, healthcare, electronics, transportation and speciality technology industries worldwide. Its main product lines include electrolytic separation membranes used in lithium and industrial batteries, filtration membranes used in kidney dialysis, blood oxygenation, and plasmapheresis medical devices, and other filtration products used in semiconductor, microelectronics, food and beverage, and water purification applications. The company makes its products in 10 facilities throughout Europe, Asia and North America. Contact: GTCR Golder Rauner LLC, 6100 Sears Tower, Chicago, IL 60606-6402, USA. Tel: +1 312 382 2200, Fax: +1 312 382 2201, www.gtcr.com Or contact: Warburg Pincus LLC, 466 Lexington Avenue, New York, NY 10017-3147, USA. Tel: +1 212 878 0600, Fax: +1 212 878 9100, www.warburgpincus.com
The European Commission has approved General Electric’s US$9.5bn acquisition of Amersham Plc, according to the Dow Jones. The deal is important to GE, which has worked hard to overcome its rancorous history with European authorities and wants to continue expanding its medical division. Amersham has three main business areas: medical diagnostics, operating as Amersham Health, and protein separations and discovery systems, together operating as Amersham Biosciences. Amersham’s diagnostic pharmaceutical and life sciences business will add new, high-growth platforms to GE Medical’s diagnostic imaging, services and healthcare IT businesses. Contact: General Electric Co, Fairfield, CT 06431, USA. Tel: +1 203 373 2211, www.gemedicalsystems.com Or contact: Amersham Plc, Little Chalfont, Buckinghamshire, UK. Tel: +44 1494 544000, www.amersham.com
Contents
Millipore and HyClone form bioprocessing alliance In the US, Millipore has formed a bioprocessing alliance with HyClone Laboratories, which develops culture consumables and disposable bioprocess liquid containment products. The companies say that the move will give biopharmaceutical manufacturers one supplier contact for the design, development and validation support of disposable manufacturing systems combining HyClone’s bioprocess containers with Millipore’s disposable separation products. Disposable processing systems were initially seen as cost-saving measures, but now proven benefits include lower costs, less downtime, enhanced process security and greater process flexibility. Disposable manufacturing also enables companies to run multiple products in a single plant without risking cross-contamination. Through this relationship, HyClone and Millipore will jointly address customers’ needs for disposable combined products for pilot
plant, process development and production applications. Future innovations required to meet evolving industry demands for combined products will come through the partners’ complementary R&D efforts in separation technology, validation and applications engineering. HyClone, which is owned by Fisher Scientific International, manufactures sera, liquid and powdered media, sterile liquids and sterile liquid handling systems to support research and production of biopharmaceuticals. Contact: Millipore Corporation, 290 Concord Road, Billerica, MA 01821, USA. Tel: +1 978 715 4321, Fax: +1 781 533 3110, www.millipore.com Or contact: Fisher Scientific International Inc, One Liberty Lane, Hampton, NH 03842, USA. Tel: +1 603 926 5911, Fax: +1 603 929 2449, www.fisherscientific.com
ISSN 0958-2118/04 © 2004 Elsevier Ltd. All rights reserved This journal and the individual contributions contained in it are protected under copyright by Elsevier Ltd, and the following terms and conditions apply to their use: Photocopying Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use.
News
1–4
In Brief
3, 4
Feature: Slotted pore microfilters for oil/water filtration, fractionation and aggressive filtration environments 5–10 Patents
10–14
Research Trends
14–16
Events Calendar
15
Polypore agrees to be acquired by Warburg Pincus EC approves GE Polypore develops, manufactures and markets takeover of Amersham Polypore Inc, a US-based supplier of membranes and filtration products, has entered into a definitive agreement under which it will be acquired by affiliates of Warburg Pincus LLC from shareholders led by The InterTech Group Inc and GTCR Golder Rauner LLC. The agreement is subject to customary closing conditions, including regulatory approval, and the transaction is expected to be completed during the second quarter of 2004. The terms of the sale were not disclosed. ‘Warburg Pincus’ global franchise and domain expertise in the industrial, technology and healthcare sectors were instrumental in our ability to execute this investment and understand the potential of Polypore,’ says Kewsong Lee, a Warburg Pincus managing director. David Donnini, senior principal at GTCR, comments: ‘Over the course of our ten-year investment, Polypore has grown from a niche manufacturer of membranes into a leading global company serving multiple high-growth markets.’
specialized microporous filtration products used in the power, storage, healthcare, electronics, transportation and speciality technology industries worldwide. Its main product lines include electrolytic separation membranes used in lithium and industrial batteries, filtration membranes used in kidney dialysis, blood oxygenation, and plasmapheresis medical devices, and other filtration products used in semiconductor, microelectronics, food and beverage, and water purification applications. The company makes its products in 10 facilities throughout Europe, Asia and North America. Contact: GTCR Golder Rauner LLC, 6100 Sears Tower, Chicago, IL 60606-6402, USA. Tel: +1 312 382 2200, Fax: +1 312 382 2201, www.gtcr.com Or contact: Warburg Pincus LLC, 466 Lexington Avenue, New York, NY 10017-3147, USA. Tel: +1 212 878 0600, Fax: +1 212 878 9100, www.warburgpincus.com
The European Commission has approved General Electric’s US$9.5bn acquisition of Amersham Plc, according to the Dow Jones. The deal is important to GE, which has worked hard to overcome its rancorous history with European authorities and wants to continue expanding its medical division. Amersham has three main business areas: medical diagnostics, operating as Amersham Health, and protein separations and discovery systems, together operating as Amersham Biosciences. Amersham’s diagnostic pharmaceutical and life sciences business will add new, high-growth platforms to GE Medical’s diagnostic imaging, services and healthcare IT businesses. Contact: General Electric Co, Fairfield, CT 06431, USA. Tel: +1 203 373 2211, www.gemedicalsystems.com Or contact: Amersham Plc, Little Chalfont, Buckinghamshire, UK. Tel: +44 1494 544000, www.amersham.com
Contents
Millipore and HyClone form bioprocessing alliance In the US, Millipore has formed a bioprocessing alliance with HyClone Laboratories, which develops culture consumables and disposable bioprocess liquid containment products. The companies say that the move will give biopharmaceutical manufacturers one supplier contact for the design, development and validation support of disposable manufacturing systems combining HyClone’s bioprocess containers with Millipore’s disposable separation products. Disposable processing systems were initially seen as cost-saving measures, but now proven benefits include lower costs, less downtime, enhanced process security and greater process flexibility. Disposable manufacturing also enables companies to run multiple products in a single plant without risking cross-contamination. Through this relationship, HyClone and Millipore will jointly address customers’ needs for disposable combined products for pilot
plant, process development and production applications. Future innovations required to meet evolving industry demands for combined products will come through the partners’ complementary R&D efforts in separation technology, validation and applications engineering. HyClone, which is owned by Fisher Scientific International, manufactures sera, liquid and powdered media, sterile liquids and sterile liquid handling systems to support research and production of biopharmaceuticals. Contact: Millipore Corporation, 290 Concord Road, Billerica, MA 01821, USA. Tel: +1 978 715 4321, Fax: +1 781 533 3110, www.millipore.com Or contact: Fisher Scientific International Inc, One Liberty Lane, Hampton, NH 03842, USA. Tel: +1 603 926 5911, Fax: +1 603 929 2449, www.fisherscientific.com
ISSN 0958-2118/04 © 2004 Elsevier Ltd. All rights reserved This journal and the individual contributions contained in it are protected under copyright by Elsevier Ltd, and the following terms and conditions apply to their use: Photocopying Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use.
News
1–4
In Brief
3, 4
Feature: Slotted pore microfilters for oil/water filtration, fractionation and aggressive filtration environments 5–10 Patents
10–14
Research Trends
14–16
Events Calendar
15